Paper4608063
Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum.
Rieckmann KH and 4 others. Trans R Soc Trop Med Hyg, 1974. Cited by 171 papers, by iCite.
Cite this record
ConductScience Library. Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Papers, record 4608063. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4608063
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Malaria | Major topic |
| Plasmodium falciparum | Major topic |
| Animals | |
| Anopheles | |
| Ethiopia | |
| Humans | |
| Immunologic Techniques | |
| Insect Vectors | |
| Radiation Effects | |
| Spores |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01082341 | Immunization of Human Volunteers With P. Vivax Irradiated Sporozoites | Background |
Source ClinicalTrials.gov
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 171 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41050675 | Controlled human malaria infection studies: insights into recent advances and key immunological and ethical implementation lessons. | Front Immunol | 2025 | https://conductscience.org/library/papers/41050675 | PubMed |
| 38656211 | Vaccines and monoclonal antibodies: new tools for malaria control. | Clin Microbiol Rev | 2024 | https://conductscience.org/library/papers/38656211 | PubMed |
| 38307966 | Profiling the antibody response of humans protected by immunization with Plasmodium vivax radiation-attenuated sporozoites. | Sci Rep | 2024 | https://conductscience.org/library/papers/38307966 | PubMed |
| 37571809 | Sporozoite immunization: innovative translational science to support the fight against malaria. | Expert Rev Vaccines | 2023 | https://conductscience.org/library/papers/37571809 | PubMed |
| 37014087 | Memory CD8+ T cell-mediated protection against liver-stage malaria. | Immunol Rev | 2023 | https://conductscience.org/library/papers/37014087 | PubMed |
| 35641527 | Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens. | NPJ Vaccines | 2022 | https://conductscience.org/library/papers/35641527 | PubMed |
| 34243763 | Early whole blood transcriptional responses to radiation-attenuated Plasmodium falciparum sporozoite vaccination in malaria naïve and malaria pre-exposed adult volunteers. | Malar J | 2021 | https://conductscience.org/library/papers/34243763 | PubMed |
| 34135099 | Dissection-independent production of Plasmodium sporozoites from whole mosquitoes. | Life Sci Alliance | 2021 | https://conductscience.org/library/papers/34135099 | PubMed |
| 34025684 | Identification, Selection and Immune Assessment of Liver Stage CD8 T Cell Epitopes From Plasmodium falciparum. | Front Immunol | 2021 | https://conductscience.org/library/papers/34025684 | PubMed |
| 33947856 | Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial. | Nat Commun | 2021 | https://conductscience.org/library/papers/33947856 | PubMed |
| 33481638 | Progress towards the development of a P. vivax vaccine. | Expert Rev Vaccines | 2021 | https://conductscience.org/library/papers/33481638 | PubMed |
| 32662772 | Proteome-wide analysis of a malaria vaccine study reveals personalized humoral immune profiles in Tanzanian adults. | Elife | 2020 | https://conductscience.org/library/papers/32662772 | PubMed |
| 31621832 | Chemoprophylaxis Vaccination: Phase I Study to Explore Stage-specific Immunity to Plasmodium falciparum in US Adults. | Clin Infect Dis | 2020 | https://conductscience.org/library/papers/31621832 | PubMed |
| 31231377 | Vaccination With Sporozoites: Models and Correlates of Protection. | Front Immunol | 2019 | https://conductscience.org/library/papers/31231377 | PubMed |
| 30675854 | The Controlled Human Malaria Infection Experience at the University of Maryland. | Am J Trop Med Hyg | 2019 | https://conductscience.org/library/papers/30675854 | PubMed |
| 29943719 | Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian Adults. | Am J Trop Med Hyg | 2018 | https://conductscience.org/library/papers/29943719 | PubMed |
| 29554084 | A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein. | Nat Med | 2018 | https://conductscience.org/library/papers/29554084 | PubMed |
| 29438525 | Immunization of Malaria-Preexposed Volunteers With PfSPZ Vaccine Elicits Long-Lived IgM Invasion-Inhibitory and Complement-Fixing Antibodies. | J Infect Dis | 2018 | https://conductscience.org/library/papers/29438525 | PubMed |
| 29371619 | Immunization with Transgenic Rodent Malaria Parasites Expressing Pfs25 Induces Potent Transmission-Blocking Activity. | Sci Rep | 2018 | https://conductscience.org/library/papers/29371619 | PubMed |
| 28923897 | Controlled Human Malaria Infection: Applications, Advances, and Challenges. | Infect Immun | 2018 | https://conductscience.org/library/papers/28923897 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4608063
GET https://conductscience.org/api/papers/v1/4608063/cited_by?page=2